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Abstract
Background: Embryos selection is crucial to maintain high performance in terms of pregnancy rate, reducing the risk 
of multiple pregnancy during IVF. Pronuclear and nucleolar characteristics have been proposed as an indicator of 
embryo development and chromosomal complement in humans, providing information about embryo viability.
Methods: To correlate the zygote-score with the maternal age and the outcome of pregnancy, we analyzed the 
pronuclear and nucleolar morphology, the polar body alignment and the zygote configuration in 459 clinical 
pregnancies obtained by IVF and ICSI in our public clinic in Reggio Emilia, Italy. We derived odds ratios (OR) and 
Corenfield's 95% confidence intervals (CI). Continuous variables were compared with Student's t-test; P lower than .05 
was considered statistically significant.
Results: We observed a significant increase of "A" pronuclear morphology configuration in 38-41 years old patients in 
comparison to that lower than or equal to 32 years old and a significant decrease of "B" configuration in 38-41 years old 
patients in comparison to that lower than or equal to 32 and in comparison to that of 33-37 years old.
Related to maternal age we found no significant differences in P1 and in P2 configuration. We found no correlation
between zygote-score, embryo cleavage and embryo quality.
Conclusions: Our results confirm the limited clinical significance of zygote-score suggesting that it can not be 
associated with maternal age, embryo cleavage and embryo quality. The evaluation of embryo quality based on 
morphological parameters is probably more predictive than zygote-score.
Background
One of the most important problems in In Vitro Fertiliza-
tion (IVF) treatments is the selection of the best embryos
for transfer, a crucial point to maintain high performance
in terms of pregnancy rate, reducing at the same time the
risk of multiple pregnancy. Nowadays, the quality evalua-
tion and the selection of in vitro obtained embryos are
made on the basis of morphological parameters involving
embryo development, uniformity of blastomeres, per-
centage of fragmentation, cytoplasmic irregularities, rate
of cleavage, blastomeres multinucleation and other visi-
ble features [1-5]. These assessments are non-invasive for
the embryo development, but on the other hand can not
provide any information about embryonic chromosomal
arrangement, one of the most relevant aspects of human
reproduction, both in vivo and in vitro. In fact, alterations
of chromosomic copy number (aneuploidies) are com-
mon in human oocytes and embryos and seem to be
mostly implicated in the first-trimester abortions, a com-
plication affecting 50%-70% of all spontaneous concep-
tions [6]. As described, autosomal trisomies and sex
chromosome monosomies, followed by polyploidy and
structural rearrangements show a global range from 50%
to 80% in first-trimester miscarriages [7,8].
An important contribution in the evaluation of embryo
quality seems to come from the pronuclear and nucleolar
characteristics, proposed as an indicator of embryo
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fertilized oocytes [9-15]. Nucleoli are the sites of the syn-
thesis of pre-RNA, and ribosomal RNA (rRNA) is neces-
sary for the translational process whereby the embryonic
genome becomes fully activated [16]. Despite the high
number of studies conducted, to date there are conflict-
ing data about the clinical efficacy of zygote-score: in fact,
recent data show that scoring system based on pronuclear
morphology seems to provide a good criterion to select
embryos for transfer when combined with embryo mor-
phology evaluation on Days 2 and 3 [14] other authors
concluded that late parameters (such as the cell number
and embryo grade) have a better prognostic value than
zygote score when selecting embryos for transfer [17-19].
Finally, to overcome definitely the problem of aneu-
ploidy during IVF, preimplantation genetic diagnosis
(PGD) and preimplantation genetic screening (PGS) have
been proposed as alternative approaches for embryo
selection based on chromosomal arrangement [20], but
their efficacy is still debatable [21]. In fact, although sev-
eral studies have reported an increase in implantation
rates and take home baby rates following PGD [22-25]
other have failed to show any positive effect of this tech-
nique [26-30]. Moreover, one report showed that PGS
can have a detrimental effect on pregnancy outcomes
[31].
Since several studies seem to confirm that aneuploidy
in the human oocytes and embryos tend to increase with
the advancing maternal age exceeding 50% by the age 40
years old [32,33], the aim of this study was correlate the
pronuclear and nucleolar characteristics with the mater-
nal age and the outcome of pregnancy.
Methods
Patients
We analyzed the pronuclear morphology, the nucleolar
morphology, the polar body alignment and the zygote
configuration in 459 clinical pregnancies obtained by
conventional IVF (IVF) (202 clinical pregnancies) and
IntraCytoplasmic Sperm Injection (ICSI) (257 clinical
pregnancies) between January 2006 and June 2009 in our
public clinic in Reggio Emilia, Italy. We stratified the
patients according with maternal age in three groups: (i)
patients ≤32 years old, (ii) patients 33-37 years old and
(iii) patients 38-41 years old.
All of the women and men included in the study had a
normal karyotype, normal hormonal assessments, nega-
tive vaginal or urethral cultures, and had no malignancy
or systemic diseases. The maternal age was 35.9 ± 4.0.
Before ovarian stimulation, every woman underwent
clinical and psychological examinations as well as trans-
vaginal ultrasound and hormonal evaluations and all
male patients underwent a preliminary sperm analysis.
The analyzed IVF and ICSI cycles were performed
under the reproductive Italian law 40/2004 that allowed
the insemination of not more than three oocytes per
cycle with the subsequent transfer of all the obtained
embryos [34].
The study was approved by the local ethics committee.
Ovarian stimulation, oocyte retrieval and sperm analysis
Ovarian down regulation was obtained with a long luteal
leuprolide acetate protocol (Enantone 3.75 mg; Takeda,
Milano, Italy) or leuprolide acetate micro dose flare pro-
tocol (Enantone 0.1 mg; Takeda) [35].
Fourteen to 20 days were needed for complete ovarian
suppression, as assessed by serum estradiol concentra-
tions (E2 <50 pg/mL) and ovarian ultrasound (no follicles
>10 mm). When the suppression criteria were satisfied,
recombinant follicle-stimulating hormone (75 IU FSH;
Gonal F; Serono, Rome, Italy) was started, using three to
six ampule (225-450 IU/day) for the following 5 days. The
ovarian response was then monitored daily by transvagi-
nal ultrasound and serum E2 assays. The recombinant
FSH dosage was adjusted individually according to the
ovarian response as judged by both serum E2 levels and
follicular growth. When one or more follicles >17 mm in
diameter and serum E2 levels of 200 pg/mL per follicle
<15 mm in diameter were obtained, 10,000 IU human
chorionic gonadotropin (hCG) was administrated intra-
muscularly. Thirty-six hours after hCG administration,
we performed oocyte retrieval by ultrasound-guided
transvaginal aspiration.
All patients undergoing embryo transfer received sup-
plemental progesterone intramuscularly (100 mg/day for
15 days; Prontogest, AMSA, Milano, Italy), or vaginally
(400 mg/day for 15 days; Prometrium; Rottapharm,
Milano, Italy).
Semen preparation, oocyte insemination and embryo 
culture
Semen samples were collected by masturbation after 3 to
5 days of abstinence. The preparation for IVF or ICSI was
performed as described elsewhere [36]. Briefly, an appro-
priate aliquot of fresh semen was diluted with 10 mL of
buffer medium (Cook IVF, Melbourne, Australia); after
centrifugation (10 minutes at 800 × g at room tempera-
ture), the supernatant was removed and replaced by
another 5 mL of buffer medium. After a second centrifu-
gation, the supernatant was once again removed, and the
pellet was overlaid with 1 mL of medium and incubated
(37°C, 6% CO2 in air) to separate by swim up.
After liquefaction, in case of poor semen (sperm con-
centration <1 × 106/mL), the sample was concentrated by
one centrifugation (1500 × g) and the pellet removed in 1
mL of medium. All conventional IVF procedures had a
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strict Kruger's criteria) and/or a number of activated
spermatozoa ≥1.5 × 106/ml after capacitation, and
oocytes were cultured individually and inseminated in
microdrops of fresh medium (Cook, IVF, Melbourne,
Australia), under mineral oil. For ICSI, following removal
of the oocyte's surrounding cumulus and corona cells,
nuclear maturation assessment was performed using an
inverted microscope to ensure the injection of metaphase
II oocytes exclusively. The ICSI procedure was performed
as reported by Palermo and coworkers [37].
Assessment of fertilization, embryo cleavage and embryo 
quality
Oocyte fertilization was assessed 18 to 20 hours after IVF
or ICSI by confirmation of the presence and location of
two pronuclei (2PN) and the alignment of nucleolar pre-
cursor bodies (NPB), concomitantly with assignment of
the pronuclear morphology score [9]. The observation of
2PN was performer using an inverted microscope with
Hoffman modulation contrast using a magnification of
×400 (TE 2000 U, Nikon Corp., Tokyo, Japan).
For pronuclear morphology score five different config-
urations regarding pronuclear morphology (A-E), four
configurations regarding nucleolar morphology (1, 2, 3,
4) and three configurations regarding polar body align-
ment (α, β, γ) were adopted as reported by Gianaroli and
coworkers [9] (Figure 1).
We classified any zygote (Figure 2) as Pattern 1 (P1) or
Pattern 2 (P2) on the basis of 2PN zygote score: we con-
sidered P1 all zygotes classified as A1α, A2β and A3β, and
P2 all the other zygotes (Figure 1). As reported by Gian-
aroli et al [9], zygote configurations A1α, A2β and A3β
correspond with an higher prognostic value for embryo
development and pregnancy rate. On the contrary, all
other zygote configurations correspond with a lower
prognostic value.
Embryo cleavage and embryo quality were evaluated 48
hours after insemination. For embryo quality assessment
we followed the method of Plachot et al [38]. For embryo
cleavage evaluation we recorded a numeric score for reg-
ularity of the blastomeres (dimension, shape), percentage
of fragmentation, and appearance of the cytoplasm [39].
A score 0 was given if the blastomeres were regular in
shape and dimension, the embryo did not show fragmen-
tation, and the cytoplasm was homogeneous without vac-
uoles or granulations. Embryos with total score 0 were
classified as ''excellent quality embryos,'' whereas in the
absence these characteristics, the embryos were given
different scores and considered to be ''non excellent''
embryos. All available embryos were trasnferred 48 hours
after insemination (Day 2).
Figure 1 Different configurations used for pronuclear morphology, nucleolar morphology and polar body alignement assessment. Pronu-
clear morphology is classified as A-E, nucleolar morphology is classified as 1-4 and polar body alignement is classified as α, β or γ (9).
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Clinical pregnancy was defined as at least one fetus with a
positive heartbeat revealed by transvaginal sonography 4
or 5 weeks after embryo transfer. Implantation rate was
defined as the number of gestational sacs on ultrasound
as a percentage of the embryos transferred.
Analysis
For all cycles we evaluated maternal age, sperm concen-
tration, sperm motility percentage and sperm morphol-
ogy. Moreover, total number of recovered and injected
oocytes, cleavage rate and total number of embryos
obtained were evaluated. For each zygote we evaluated
pronuclear morphology, nucleolar morphology, polar
Figure 2 Zygotes showing different distribution of NPB in the 2PN and different PB aligment (Original magnification ×400). Zygotes ob-
served after 18-20 hours after insemination. (A) 2PN centralized and juxtaposed, NPBs aligned on the side of the 2PN, longitudinal PB alignment. (B) 
2PN centralized and juxtaposed, NPBs dispersed in the 2PN, perpendicular PB alignment. (C) 2PN centralized and juxtaposed, NPBs non polarized with 
dispersed or not completely aligned NPBs in the 2PN, longitudinal PB alignment. (D) 2PN centralized and juxtaposed, NPBs aligned on the side of the 
2PN, neither longitudinal nor perpendicular PB alignment. Black narrows indicate the PBs. (A) and (B) were examples of zygotes included in Pattern 1 
group, while (C) and (D) were examples of zygotes included in Pattern 2 group.
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embryo quality. Then, we evaluated implantation rate.
All data were entered in Excel. We derived odds ratios
(OR) and Corenfield's 95% confidence intervals (CI).
Continuous variables were compared with Student's t-
test; P < .05 was considered statistically significant.
Results
In the present study we analyzed the pronuclear and
nucleolar morphology, the polar body alignment and the
zygote configuration in 459 clinical pregnancies obtained
by IVF (202 clinical pregnancies) and ICSI (257 clinical
pregnancies).
Table 1: Biological and clinical results in IVF cycles.
Parameter ≤32 33-37 38-41 Total Statistics
Cycles with clinical pregnancy 107 196 156 459
IVF 41 90 71 202 n.s.*
ICSI 66 106 85 257 n.s.*
Patients with clinical pregnancy 105 182 149 436
Maternal age (mean ± SD) 30.3 ± 2.4 35.7 ± 1.4 40.0 ± 1.3 35.9 ± 4.0
IVF attemps (mean) (1.0) (1.1) (1.1) (1.1)
Retrieved oocytes°(mean ± SD) 728 (6.8 ± 3.5) 1273 (6.5 ± 3.5) 954 (6.1 ± 3.1) 2955 (6.4 ± 3.4) n.s
Inseminated oocytes°(mean ± SD) 306 (2.9 ± 0.6) 569 (2.9 ± 0.6) 451 (2.9 ± 0.8) 1326 (2.9 ± 0.7) n.s
2 pronucleate zygotes°(mean ± SD) 240 (2.2 ± 0.8) 478 (2.4 ± 0.7) 360 (2.3 ± 0.8) 1078 (2.3 ± 0.8) n.s.
2 pronucleate zygotes°(%) 78.4 84.0 79.8 81.3 0.692 (0.487-0.984)§
Cleaved and transferred 
embryos°(mean ± SD)
235 (2.2 ± 0.8) 474 (2.4 ± 0.7) 353 (2.3 ± 0.8) 1062 (2.3 ± 0.8) <0.05**
Implantation rate°(%) 107/235 (45.5) 196/474 (41.3) 156/353 (44.2) 459/1062 (43.2) n.s.
* not statistically significant both for maternal ages and for insemination technique
°all values referred to cycle number
§ ≤32 vs. 33-37, O.R. (C.I. 95%)
** ≤32 vs. 33-37, p value significative < 0.05
Table 2: Pronuclear morphology in zygotes related to the maternal age.
Clinical pregnancies Ongoing pregnancies/deliveries
≤32 33-37 38-41 O.R. (C.I. 95%) ≤32 33-37 38-41 O.R. (C.I. 95%)
A 172 (72.0) 330 (69.8) 281 (79.4) 0.667 (0.456-0.976)*
0.600
(0.434-0.828)°
125 (69.1) 275 (67.9) 195 (81.2) 0.511
(0.328-0.808)*
0.484
(0.330-0.711)°
B 55 (23.0) 123 (26.0) 53 (15.0) 1.698
(1.118-2.578)*
1.996
(1.398-2.849)°
44 (24.3) 116 (28.3) 34 (14.2) 2.099
(1.278-3.448)*
2.424
(1.592-3.687)°
C 9 (3.8) 11 (2.3) 11 (3.1) n.s. 9 (5.0) 9 (2.2) 8 (3.4) n.s.
D 3 (1.3) 9 (1.9) 9 (2.5) n.s. 3 (1.6) 6 (1.5) 3 (1.2) n.s.
E 0 (0.0) 0 (0.0) 0 (0.0) n.s. 0 (0.0) 0 (0.0) 0 (0.0) n.s.
All 
zygotes
239 473 354 181 406 240
* ≤32 vs. 38-41
°33-37 vs. 38-41
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nificant differences in terms of IVF and ICSI distribution
in our population, retrieved oocytes per cycle, insemi-
nated oocytes, 2 pronucleate zygotes, and implantation
rate between patients ≤32 years old, 33-37 years old and
38-41 years old. On the contrary, we found a statistically
significant increase of fertilization rate in patients 33-37
years old in comparison to patients ≤ 32 years old (84.0%
vs. 78.4%, O.R. 0.692;C.I. 95% 0.487-0.984) and an
increase in cleaved and transferred embryos in patients
33-37 years old in comparison to patients ≤32 years old (p
< 0.05).
The assessment of pronuclear morphology (Table 2)
showed a statistically significant increase in clinical preg-
nancies in "A" configuration in 38-41 years old patients in
comparison to ≤ 32 years old patients (79.4% vs.. 72.0%,
O.R. 0.667;C.I. 95% 0.456-0.976) and in comparison to
33-37 years old patients (79.4% vs.. 69.8%, O.R. 0.600;C.I.
95% 0.434-0.828). The same trend was observed in ongo-
ing pregnancies/deliveries (Table 2).
Moreover, the pronuclear morphology analysis showed
an opposite trend in "B" configuration (Table 2): in fact,
we observed a statistically significant decrease in clinical
pregnancies in "B" configuration in 38-41 years old
patients in comparison to ≤ 32 years old patients (15.0%
vs. 23.0%, O.R. 1.698;C.I. 95% 1.118-2.578) and in com-
parison to 33-37 years old patients (15.0% vs. 26.0%, O.R.
1.996;C.I. 95% 2.398-2.849). Similarly, we found the same
trend in ongoing pregnancies/deliveries (Table 2).
We did not observe any statistically significant differ-
ences in "C", "D" and "E" configurations related to mater-
nal age both in clinical pregnancies and in ongoing
pregnancies/deliveries (Table 2).
In nucleolar morphology analysis, we found no statisti-
cally significant differences in all considered configura-
tions (1, 2, 3, 4) related to maternal age both in clinical
pregnancies and in ongoing pregnancies/deliveries (Table
3).
In Table 4 are reported the results of polar body align-
ment analysis. We found a statistically significant
increase of "β" configuration in 33-37 years old patients
compared with 38-41 years old patients both in clinical
pregnancies (31.1% vs. 37.9%, O.R. 0.740;C.I. 95% 0.554-
0.989), and in ongoing pregnancies/deliveries. On the
contrary, in "α" and "γ" configurations we found no statis-
tically significant differences related to maternal age in
clinical pregnancies and in ongoing pregnancies/deliver-
ies (Table 4).
Moreover, we found no statistically significant differ-
ences correlating P1 (A1α, A2β and A3β) and P2 (pool of
all the other configurations) configurations with embryo
cleavage and embryo quality in clinical pregnancies
(Table 5). We observed a similar trend in ongoing preg-
nancies/deliveries (data not showed). Finally, we found no
Table 3: Nucleolar morphology related to the maternal age.
Clinical pregnancies Ongoing pregnancies/deliveries
≤32 33-37 38-41 O.R. (C.I. 
95%)
≤32 33-37 38-41 O.R. (C.I. 
95%)
1 134 (56.1) 274 (57.9) 193 (54.5) n.s. 96 (53.0) 230 (56.6) 132 (55.0) n.s.
2 37 (15.5) 65 (13.7) 60 (16.9) n.s. 32 (17.7) 62 (15.3) 37 (15.4) n.s.
3 53 (22.2) 106 (22.4) 86 (24.3) n.s. 41 (22.6) 88 (21.7) 61 (25.4) n.s.
4 15 (6.3) 28 (5.9) 15 (4.2) n.s. 12 (6.6) 26 (6.4) 10 (4.2) n.s.
All 
zygotes
239 473 354 181 406 240
Table 4: Polar body alignment related to the maternal age
Clinical pregnancies Ongoing pregnancies/deliveries
≤32 33-37 38-41 O.R. (C.I. 95%) ≤32 33-37 38-41 O.R. (C.I. 95%)
α 118 (49.4) 247 (52.2) 165 (46.6) n.s 91 (50.3) 213 (52.5) 111 (46.2) n.s
β 82 (34.3) 147 (31.1) 134 (37.9) 0.740 (0.554-0.989)° 62 (34.2) 123 (30.3) 94 (39.2) 0.675 (0.483-0.943)°
γ 39 (16.3) 79 (16.7) 55 (15.5) n.s 28 (15.5) 70 (17.2) 35 (14.6) n.s.
All 
zygotes
239 473 354 181 406 240
°33-37 vs. 38-41
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rations related to maternal age in clinical pregnancies.
Similarly, we found the same result in ongoing pregnan-
cies/deliveries (Figure 3).
Discussion
One of the main items of IVF treatments is maintain an
high performance in terms of pregnancy rate reducing at
same time the multiple gestations; the selection of the
best embryo/embryos to transfer is a key step to achieve
this objective. Nowadays, the embryo selection is mainly
performed on the basis of visible morphological parame-
ters [2-5], but this assessment can not provide any infor-
mation about embryonic aneuploidies, a problem
increasing with the advancing maternal age [32,33], and
probably implicated in the most of the first-trimester
spontaneous miscarriages [8]. The evaluation of the pro-
nuclear and nucleolar characteristics (zygote-score) has
been proposed as an indicator of embryo development
and chromosomal complement in human fertilized
oocytes [13-19]. The study of human zygote seem to pro-
vide important information about embryonic chromo-
somal arrangements, even if, to date, there is no definitive
scientific evidence about its clinical efficacy [17,18].
Recent data seem to consider pronuclear evaluation as a
good criterion when combined with embryo morphology
evaluation on Days 2 and 3 [14], other authors conclude
that late parameters (number of blastomeres and embryo
grade) have a better prognostic value than zygote score
[19].
In the present study, we have evaluated the clinical sig-
nificance of zygote-score related to maternal age in
patients submitted to ART cycles successfully, obtaining a
clinical pregnancy. We observed that all parameters ana-
lyzed (pronuclear morphology, nucleolar morphology,
polar body alignment and zygote configuration) were
generally uniformly distributed in patients ≤32 years old,
33-37 years old and 38-41 years old, showing only few dif-
ferences related to maternal ages.
Studying the pronuclear morphology, we observed a
statistically significant increase in "A" configuration, with
a concomitant decrease in "B" configuration, in 38-41
years old in comparison to ≤37 years old patients, both in
clinical pregnancies and in ongoing pregnancies/deliver-
ies groups. Due to our unique population characteristics
(all patients with clinical pregnancy and maternal age
subdivision), it is difficult to compare our results with
others present in literature, nevertheless these results
appear to corroborate with what has been reported in lit-
erature [9]. In agreement with previously reported data
[19], our analysis of nucleolar morphology showed no
statistically significant differences in relation to maternal
ages, both in clinical pregnancy and in ongoing preg-
nancy/deliveries groups. This result is in contrast with
recently published data showing a correlation between
pronuclear morphology and maternal ages [15]. We
believe that the discrepancy could be related to the differ-
ent sample size and to the different maternal age between
our patients and those analyzed by Maille and coworkers.
Moreover, in contrast with Maille and coworkers, we
Table 5: Zygote morphology related to embryo cleavage and embryo quality.
P1 P2
≥4 blastomeres Excellent Quality ≥4 blastomeres Excellent Quality OR (IC 95%)
<32 79/89 (88.8) 40/89 (44.9) 123/150 (82.0) 56/150 (37.3) n.s
33-37 134/170 (78.8) 65/170 (38.2) 224/303 (73.9) 113/303 (37.3) n.s
38-41 101/128 (78.9) 55/128 (43.0) 185/226 (81.9) 94/226 (41.6) n.s
Total 314/387 (81.1) 162/387 (41.9) 532/679 (78.4) 258/679 (38.0)
Figure 3 P1 and P2 distributions in ongoing pregnancies/deliver-
ies group. Pattern 1 (P1) and Pattern 2 (P2) distributions in ongoing 
pregnancies/deliveries groups. We classified any zygote as P1 or P2 on 
the basis of 2PN zygote score: we considered P1 all zygotes classified 
as A1α, A2β and A3β, and P2 all the other zygotes.
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obtained both with IVF and ICSI. Again, more recent
data seem to confirm the poor clinical significance of
nucleolar morphology during embryo selection, report-
ing no correlations between this parameter and implanta-
tion rate [19].
Finally, studying the last zygote parameter - polar body
alignment - related to maternal age, our data showed a
statistically significant decrease of "β" configuration in
patients 38-41 years old, both in clinical pregnancies and
in ongoing pregnancies/deliveries group. We can specu-
late that polar body alignment, usually evaluated during
zygote-score assessment, not appear to have a prognostic
value in terms of embryo viability and pregnancy rate.
Than, it can not be considered a good tool to select the
best embryo to transfer.
This assumption seems to be confirmed by the evalua-
tion of the last parameter considered in our analysis: the
whole zygote configuration (pronuclear and nucleolar
morphologies plus polar body alignment). In particular,
the total absence of statistically significant differences
between zygote configurations P1 and P2 grouped by
maternal ages, probably provide an additional evidence
about the limited importance of zygote-score in assisted
reproduction outcomes, as proposed by our previously
data and confirmed by most recently published results
[18,19]. Our results showed any statistical significance in
term of embryo cleavage and embryo quality related to P1
or P2 configurations both in clinical pregnancies and in
ongoing pregnancies/deliveries.
Conclusions
In conclusion, the results of our study confirm that
zygote-score assessment have a limited clinical signifi-
cance in the choice of the best embryos to transfer during
IVF treatments. Probably, as proposed by other authors
[19,40] and suggested in this study, the evaluation of
embryo quality performed on the basis of number of blas-
tomeres, embryo morphological characteristics and
grade is more predictive than zygote-score.
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